Publications found:
36,087
Sort by:
The 2027-2032 World Outlook for Hemoglobin A1C Testing
US$ 1,195.00
This study covers the world outlook for hemoglobin A1C testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Hemoglobin Testing
US$ 1,195.00
This study covers the world outlook for hemoglobin testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Hemophilia a Drugs
US$ 1,195.00
This study covers the world outlook for hemophilia a drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Hemophilia a Gene Therapies
US$ 1,195.00
This study covers the world outlook for hemophilia a gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Hemophilia a Treatments
US$ 1,195.00
This study covers the world outlook for hemophilia a treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Hemophilia Drugs
US$ 1,195.00
This study covers the world outlook for hemophilia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Hemophilia Gene Therapies
US$ 1,195.00
This study covers the world outlook for hemophilia gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Hemophilia Treatments
US$ 1,195.00
This study covers the world outlook for hemophilia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Hemostasis Analyzers
US$ 1,195.00
This study covers the world outlook for hemostasis analyzers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Hemostasis Diagnostics
US$ 1,195.00
This study covers the world outlook for hemostasis diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Hemostasis Products
US$ 1,195.00
This study covers the world outlook for hemostasis products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Hemostasis Valves
US$ 1,195.00
This study covers the world outlook for hemostasis valves across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Hemostatic Agents
US$ 1,195.00
This study covers the world outlook for hemostatic agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Hemostats and Sealants
US$ 1,195.00
This study covers the world outlook for hemostats and sealants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Hemp-Based Foods
US$ 1,195.00
This study covers the world outlook for hemp-based foods across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Hemp Fibers
US$ 1,195.00
This study covers the world outlook for hemp Fibers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Hemp Milk
US$ 1,195.00
This study covers the world outlook for hemp milk across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co...
January 2026
287 pages
The 2027-2032 World Outlook for Hemp Seeds
US$ 1,195.00
This study covers the world outlook for hemp seeds across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the c...
January 2026
287 pages
The 2027-2032 World Outlook for HEPA Filters
US$ 1,195.00
This study covers the world outlook for HEPA filters across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for HEPA Filters Volume
US$ 1,195.00
This study covers the world outlook for HEPA filters volume across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Heparin
US$ 1,195.00
This study covers the world outlook for heparin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun...
January 2026
287 pages
The 2027-2032 World Outlook for Heparin Anticoagulants
US$ 1,195.00
This study covers the world outlook for heparin anticoagulants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Heparin Sodium
US$ 1,195.00
This study covers the world outlook for heparin sodium across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis B Diagnostic Tests
US$ 1,195.00
This study covers the world outlook for hepatitis b diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis B Vaccines
US$ 1,195.00
This study covers the world outlook for hepatitis b vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis C Drugs
US$ 1,195.00
This study covers the world outlook for hepatitis c drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis C Therapeutics
US$ 1,195.00
This study covers the world outlook for hepatitis c therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis Diagnostics
US$ 1,195.00
This study covers the world outlook for hepatitis diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis Therapeutics
US$ 1,195.00
This study covers the world outlook for hepatitis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for HER2 Antibodies
US$ 1,195.00
This study covers the world outlook for HER2 antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Herb Vapourizers
US$ 1,195.00
This study covers the world outlook for herb vapourizers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Herbal Medicinal Products
US$ 1,195.00
This study covers the world outlook for herbal medicinal products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
288 pages
The 2027-2032 World Outlook for Herbal Medicines
US$ 1,195.00
This study covers the world outlook for herbal medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
288 pages
The 2027-2032 World Outlook for Herbal and Fruit Teas
US$ 1,195.00
This study covers the world outlook for herbal and fruit teas across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Herbal and Organic Mascara
US$ 1,195.00
This study covers the world outlook for herbal and organic mascara across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for Herbal Supplements
US$ 1,195.00
This study covers the world outlook for herbal supplements across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
288 pages
The 2027-2032 World Outlook for Herbal Teas
US$ 1,195.00
This study covers the world outlook for herbal teas across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Herbal Toothcare
US$ 1,195.00
This study covers the world outlook for herbal toothcare across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Herbal Toothpaste
US$ 1,195.00
This study covers the world outlook for herbal toothpaste across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Herbicide Residue Testing
US$ 1,195.00
This study covers the world outlook for herbicide residue testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Herbicide Safeners
US$ 1,195.00
This study covers the world outlook for herbicide safeners across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
